The breast cancer treatment inavolisib will not be available to NHS patients after the UK National Institute for Health and ...
Potential cost implications of the drug pricing deal between the US and the UK will be investigated by the UK’s public spending watchdog, the organisation’s leader says. The UK signed a drug trade ...
Proposals currently out for consultation would substantially reverse the protections recommended by the Leng review, argue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results